No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 

Researchers suggest the variables identified in their study should be considered when deciding whether to send patients for additional assessments to confirm or rule out malignancy.

A federal judge has vacated five of seven complaints against UnitedHealth Group—yet is allowing the AI-implicated suit to advance. 

U.S. House Rep. Greg Murphy, MD (R-NC), scolded the CEO of NYU Langone for buying the expensive ad, requesting in an open letter that the hospital release financial data related to its cost. 

Two in five practicing physicians are equal parts enthused over and worried about AI in healthcare. That’s the same ratio the American Medical Association turned up the last time it conducted its Physician Sentiment Survey.

A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.

Adelaide, Australia, vendor Micro-X is undertaking the assignment, utilizing funds from the U.S. Advanced Research Projects Agency for Health.

End-of-life decisions are often anything but easy. AI might be able to help.